Bionik Laboratories Corp. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bionik Laboratories Corp. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q1 2023.
  • Bionik Laboratories Corp. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $255K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $255K +$255K Mar 31, 2023 10-K 2023-06-21
Q4 2022 $260K Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $265K Sep 30, 2022 10-Q 2022-11-09
Q1 2022 $0 Mar 31, 2022 10-K 2023-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.